Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iBrands Farms appears to have been a consumer-facing hemp/CBD and nutraceutical business operated as a subsidiary or brand of iBrands Corporation rather than an independent drug-development biotech company. Public disclosures and press releases describe it as a vertically integrated agribusiness and online retail operation selling hemp-derived cannabinoid products, topicals, edibles, smokables, pet products, and selected nutraceuticals. The business also served as a sales channel for Therapeutic Solutions International nutraceutical products such as NanoStilbene, NanoPSA, Nano Plus, Nano Cannabidiol, ProJuvenol, and later Nano Sport. Based on available evidence, iBrands Farms was commercial-stage in consumer wellness products, not a clinical-stage therapeutics developer. Current activity appears limited or inactive, and there is no clear evidence of an ongoing standalone operating company presence as of 2026.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iBrands Farms.